Off-label use of atypical antipsychotics in personality disorders. - Wikidata - awgldk - TriplyDB

Off-label use of atypical antipsychotics in personality disorders.

Off-label use of atypical antipsychotics in personality disorders.

http://www.wikidata.org/entity/Q37935806

about

Off-Label Prescribing by Psychiatrists: What is the Practitioner's Liability?Oscillatory responses to reward processing in borderline personality disorder.

P2860

Q34672146-D0948636-2F73-45D5-B061-D872C6B5FC35 Q50575903-A125A3F7-D294-430C-A6FF-09673462FCF5

P2860

Off-label use of atypical antipsychotics in personality disorders.

http://www.wikidata.org/entity/Q37935806

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Off-label use of atypical antipsychotics in personality disorders.

@en

Off-label use of atypical antipsychotics in personality disorders.

@nl

type

label

Off-label use of atypical antipsychotics in personality disorders.

@en

Off-label use of atypical antipsychotics in personality disorders.

@nl

prefLabel

Off-label use of atypical antipsychotics in personality disorders.

@en

Off-label use of atypical antipsychotics in personality disorders.

@nl

P1433

Q37935806-E6D8B95A-FA3A-4869-A80A-81D710B997E8

P1476

Q37935806-38F03C74-4A27-4DA5-B9BA-C0DFDE3CE722

P2093

Q37935806-06308BBD-17E1-4A9E-A481-3B998AC20338

P2860

Q37935806-02246861-2B06-47E1-BECA-D1C2125500A0

Q37935806-07A90D9F-4008-4A48-A12E-103E8B2E0E80

Q37935806-0D33D2FB-7C3E-4734-A35C-675F825E4F25

Q37935806-0DB31916-1F19-4EF2-977F-06D763982EEE

Q37935806-0FE625DB-159D-417C-A365-5C493A8ACA38

Q37935806-1441F951-60F6-4225-B6B8-A8515C5BFAD2

Q37935806-14BBE1B2-ADF3-43C3-8DD9-24275A072119

Q37935806-36294604-4C3C-4F7F-9512-F4F2E0656450

Q37935806-363F3C1A-8FA3-4948-A4D6-FBAFB64CB42B

Q37935806-38492E14-F48F-41B8-8409-EAA2DD144C71

P304

Q37935806-47ABB651-1A72-44E5-99A3-DB31F409C3EA

P31

Q37935806-CA4419DE-84BC-4B2E-9D0C-8AE8A3878CD7

P356

Q37935806-C4638B6F-145C-4E67-B4FE-3B4A5BEE392B

P407

Q37935806-1D038DBC-818E-4DE5-9A32-4247D69025D0

P433

Q37935806-3B34379D-36D4-4660-8495-171A8B2BDE22

P478

Q37935806-9BB009C9-E9B0-4C85-B3C1-98B88E028072

P50

Q37935806-209853E8-11CC-4CF3-A1E3-B20A1E1B0EFC

P577

Q37935806-A0157657-DDFE-4AA0-B5E4-AA565A72740D

P698

Q37935806-1D564F79-6FA9-469C-BCA6-63E363DA5BFC

P356

14656566.2011.608351

P1433

Expert Opinion on Pharmacotherapy

P1476

Off-label use of atypical antipsychotics in personality disorders

@en

P2093

Michael Rosenbluth

http://www.w3.org/2001/XMLSchema#string

P2860

Psychotherapy of borderline personality disorder

Increasing off-label use of antipsychotic medications in the United States, 1995-2008

Quetiapine for the treatment of borderline personality disorder; an open-label study.

Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes

Suicidal risk during treatment with clozapine: a meta-analysis.

Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials.

Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.

Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.

Broad therapeutic uses of atypical antipsychotic medications.

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.

P304

1575-1585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.608351

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21933032

http://www.w3.org/2001/XMLSchema#string